Related references
Note: Only part of the references are listed.Endocrine Side Effects Induced by Immune Checkpoint Inhibitors
Salvatore Maria Corsello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
ASSOCIATION OF IPILIMUMAB THERAPY FOR ADVANCED MELANOMA WITH SECONDARY ADRENAL INSUFFICIENCY: A CASE SERIES
Le Min et al.
ENDOCRINE PRACTICE (2012)
Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review
Agata Juszczak et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
Jeffrey S. Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Hypophysitis Induced by Monoclonal Antibodies to Cytotoxic T Lymphocyte Antigen 4: Challenges from a New Cause of a Rare Disease
Francesco Torino et al.
ONCOLOGIST (2012)
Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy
Le Min et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Thyroid Dysfunction from Antineoplastic Agents
Ole-Petter Riksfjord Hamnvik et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Drug-Induced Graves Disease From CTLA-4 Receptor Suppression
Gary Borodic et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2011)
Ipilimumab-Induced Hypophysitis: MR Imaging Findings
K. J. Carpenter et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2009)
Cytotoxic T-Lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer
JA Blansfield et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Share Paper
